Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

In Vivo clonal dynamics of alloreactive CAR T cells reveal mechanisms limiting gvhd risk following allogeneic CAR T cell therapy

Gabriele Inchingolo, Jennifer Brudno, James Kochenderfer, Luca Gattinoni

Blood (2025) 146 (Supplement 1): 105.

https://doi.org/10.1182/blood-2025-105

Published: 2025

Journal Articles

Multi-faceted influence of immunomodulatory metabolites on CAR-T cell therapy

Dhyani Shah, Markus Perl, Matthias Fante, Severin Guetter, Simon Holzinger, Luisa-Marie Becker, Misbah Tariq, Philipp Meanauer, Simon Delahais, Gloria Lutzny-Geier, Julian Scherer, Sascha Goettert, Konstantin Herfeld, Paul Heinrich, Klaus-Georg Kreitmeier, Wolfgang Herr, Janina Doerr, Dennis Harrer, Leo Hansmann, Marcel Trefny, Matthias Edinger, Daniel Wolff, Daniela Weber, Elisabeth Meedt, André Gessner, Ernst Holler, Tobias Wertheimer, Klaus Neuhaus, Tingting Zheng, Kai Ziegler-Martin, David M. Cordas Dos Santos, Sebastian Theurich, Melanie Schirmer, Jonas Schluter, Michael Schmitt, Karin Kleigrewe, Markus Feuerer, Christoph Heuser-Loy, Jeremy Baldwin, Michael Hudecek, Luca Gattinoni, Marion Subklewe, Viktoria Blumenberg, Maria-Luisa Schubert, Christoph Stein-Thoeringer, Maik Luu, Sebastian Kobold, Erik Thiele Orberg, Hendrik Poeck

Blood (2025) 146 (Supplement 1): 2343.

https://doi.org/10.1182/blood-2025-2343

Published: 2025

Journal Articles

The Phosphorylation State of Ezh2 Determines Its Capacity to Maintain CD8 + Memory T Cells for Antitumor Immunity

Shan He, PhD, Yongnian Liu, Lijun Meng, Hongxing SUN, Ying Wang, Yun Ji, Janaki Purushe, BS, Pan Chen, Changhong Li, Jozef Madzo, Jean-Pierre Issa, MD, Jonathan Soboloff, Ran Reshef, MD, Bethany Moore, Luca Gattinoni, Yi Zhang, MD

Blood (2017) 130 (Supplement 1): 4455.

https://doi.org/10.1182/blood.V130.Suppl_1.4455.4455

Published: 2017

Journal Articles

Generation of clinical-grade CD19-specific CAR-modified CD8 + memory stem cells for the treatment of human B-cell malignancies

Marianna Sabatino, Jinhui Hu, Michele Sommariva, Sanjivan Gautam, Vicki Fellowes, James D. Hocker, Sean Dougherty, Haiying Qin, Christopher A. Klebanoff, Terry J. Fry, Ronald E. Gress, James N. Kochenderfer, David F. Stroncek, Yun Ji, Luca Gattinoni

Blood (2016) 128 (4): 519–528.

https://doi.org/10.1182/blood-2015-11-683847

Published: 2016

Includes: Supplemental data

Journal Articles

The dark side of T memory stem cells

Luca Gattinoni

Blood (2015) 125 (23): 3519–3520.

https://doi.org/10.1182/blood-2015-04-640631

Published: 2015

Journal Articles

Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy

Anniek B. van der Waart, Noortje M. P. van de Weem, Frans Maas, Cynthia S. M. Kramer, Michel G. D. Kester, J. H. Frederik Falkenburg, Nicolaas Schaap, Joop H. Jansen, Robbert van der Voort, Luca Gattinoni, Willemijn Hobo, Harry Dolstra

Blood (2014) 124 (23): 3490–3500.

https://doi.org/10.1182/blood-2014-05-578583

Published: 2014

Includes: Supplemental data

Journal Articles

Akt Signalling Inhibition Promotes The Ex Vivo generation Of Minor Histocompatibility Antigen-Specific CD8+ Memory Stem T Cells

Anniek B. van der Waart, MSc, Noortje van der Weem, Luca Gattinoni, MD, Nicolaas PM Schaap, MD, PhD, Robbert van der Voort, PhD, Willemijn Hobo, PhD, Harry Dolstra, PhD

Blood (2013) 122 (21): 3269.

https://doi.org/10.1182/blood.V122.21.3269.3269

Published: 2013

Journal Articles

Moving T memory stem cells to the clinic

Luca Gattinoni, Nicholas P. Restifo

Blood (2013) 121 (4): 567–568.

https://doi.org/10.1182/blood-2012-11-468660

Published: 2013

Journal Articles

Stubborn Tregs limit T-cell therapy

Christopher A. Klebanoff, Luca Gattinoni

Blood (2012) 120 (12): 2352–2354.

https://doi.org/10.1182/blood-2012-08-445239

Published: 2012

Journal Articles

Human effector CD8 + T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy

Christian S. Hinrichs, Zachary A. Borman, Luca Gattinoni, Zhiya Yu, William R. Burns, Jianping Huang, Christopher A. Klebanoff, Laura A. Johnson, Sid P. Kerkar, Shicheng Yang, Pawel Muranski, Douglas C. Palmer, Christopher D. Scott, Richard A. Morgan, Paul F. Robbins, Steven A. Rosenberg, Nicholas P. Restifo

Blood (2011) 117 (3): 808–814.

https://doi.org/10.1182/blood-2010-05-286286

Published: 2011

Includes: Supplemental data

Journal Articles

Improving Adoptive Immunotherapy Using Less-Differentiated T Cells

Nicholas P. Restifo, MD, Madhu Sukumar, Ph.D., Luca Gattinoni, MD

Blood (2010) 116 (21): SCI-49.

https://doi.org/10.1182/blood.V116.21.SCI-49.SCI-49

Published: 2010

Journal Articles

Th17-Derived Memory Cells Are Long-Lived and Retain a Stem-Like Molecular Signature

Pawel Muranski, MD, Zachary Borman, Sid Kerkar, Yun Ji, Luca Gattinoni, MD, Reger N Robert, Luis Sanchez-Perez, Klebanoff A Christopher, Zhiya Yu, Kern J Steven, Gabriela Ferreyra, Robert L Danner, Nicholas P Restifo

Blood (2010) 116 (21): 1018.

https://doi.org/10.1182/blood.V116.21.1018.1018

Published: 2010

Journal Articles

IL-17A-Expressing CD4+ T Cells Must Acquire the Expression of T-Bet and IFN-γto Destroy Tumor Cells In Vivo.

Pawel Muranski, MD, Sid P Kerkar, Zachary A Borman, Robert Reger, Luis Sanchez-Perez, Christian S Hinrichs, Zhiya Yu, Douglas C Palmer, Luca Gattinoni, Nicholas P. Restifo

Blood (2009) 114 (22): 468.

https://doi.org/10.1182/blood.V114.22.468.468

Published: 2009

Journal Articles

Programming tumor-reactive effector memory CD8 + T cells in vitro obviates the requirement for in vivo vaccination

Christopher A. Klebanoff, Zhiya Yu, Leroy N. Hwang, Douglas C. Palmer, Luca Gattinoni, Nicholas P. Restifo

Blood (2009) 114 (9): 1776–1783.

https://doi.org/10.1182/blood-2008-12-192419

Published: 2009

Includes: Supplemental data

Journal Articles

Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers

Andrea Boni, Pawel Muranski, Lydie Cassard, Claudia Wrzesinski, Chrystal M. Paulos, Douglas C. Palmer, Luca Gattinoni, Christian S. Hinrichs, Chi-Chao Chan, Steven A. Rosenberg, Nicholas P. Restifo

Blood (2008) 112 (12): 4746–4754.

https://doi.org/10.1182/blood-2008-07-169797

Published: 2008

Includes: Supplemental data

Journal Articles

Treatment of Large Established Murine Melanoma with Th17 Polarized CD4+ T Helper Cells Genetically Engineered to Express MHC Class IIRestricted T Cell Receptor

Pawel Muranski, MD, Christian S. Hinrichs, Luis Sanchez-Perez, Andrea Boni, Sid Kerkar, Luca Gattinoni, Zhia Yu, Nicholas P. Restifo

Blood (2008) 112 (11): 3911.

https://doi.org/10.1182/blood.V112.11.3911.3911

Published: 2008

Journal Articles

Tumor-specific Th17-polarized cells eradicate large established melanoma

Pawel Muranski, Andrea Boni, Paul A. Antony, Lydie Cassard, Kari R. Irvine, Andrew Kaiser, Chrystal M. Paulos, Douglas C. Palmer, Christopher E. Touloukian, Krzysztof Ptak, Luca Gattinoni, Claudia Wrzesinski, Christian S. Hinrichs, Keith W. Kerstann, Lionel Feigenbaum, Chi-Chao Chan, Nicholas P. Restifo

Blood (2008) 112 (2): 362–373.

https://doi.org/10.1182/blood-2007-11-120998

Published: 2008

Includes: Supplemental data

Journal Articles

IL-2 and IL-21 confer opposing differentiation programs to CD8 + T cells for adoptive immunotherapy

Christian S. Hinrichs, Rosanne Spolski, Chrystal M. Paulos, Luca Gattinoni, Keith W. Kerstann, Douglas C. Palmer, Christopher A. Klebanoff, Steven A. Rosenberg, Warren J. Leonard, Nicholas P. Restifo

Blood (2008) 111 (11): 5326–5333.

https://doi.org/10.1182/blood-2007-09-113050

Published: 2008

Includes: Supplemental data

Journal Articles

CTLA-4 dysregulation of self/tumor-reactive CD8 + T-cell function is CD4 + T-cell dependent

Luca Gattinoni, Anju Ranganathan, Deborah R. Surman, Douglas C. Palmer, Paul A. Antony, Marc R. Theoret, David M. Heimann, Steven A. Rosenberg, Nicholas P. Restifo

Blood (2006) 108 (12): 3818–3823.

https://doi.org/10.1182/blood-2006-07-034066

Published: 2006

Journal Articles

Partly MHC Matched Allogeneic Tumor Specific T Cells Mediate Tumor Regression without Inducing GVHD in Immunosuppressed Host.

Andrea Boni, Pawel Muranski, Claudia Wrzesinski, Andrew Kaiser, Chrystal Paulos, Douglas Palmer, Luca Gattinoni, Nicholas P. Restifo

Blood (2006) 108 (11): 5210.

https://doi.org/10.1182/blood.V108.11.5210.5210

Published: 2006

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

In Vivo clonal dynamics of alloreactive CAR T cells reveal mechanisms limiting gvhd risk following allogeneic CAR T cell therapy

Multi-faceted influence of immunomodulatory metabolites on CAR-T cell therapy

The Phosphorylation State of Ezh2 Determines Its Capacity to Maintain CD8 + Memory T Cells for Antitumor Immunity

Generation of clinical-grade CD19-specific CAR-modified CD8 + memory stem cells for the treatment of human B-cell malignancies

The dark side of T memory stem cells

Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy

Akt Signalling Inhibition Promotes The Ex Vivo generation Of Minor Histocompatibility Antigen-Specific CD8+ Memory Stem T Cells

Moving T memory stem cells to the clinic

Stubborn Tregs limit T-cell therapy

Human effector CD8 + T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy

Improving Adoptive Immunotherapy Using Less-Differentiated T Cells

Th17-Derived Memory Cells Are Long-Lived and Retain a Stem-Like Molecular Signature

IL-17A-Expressing CD4+ T Cells Must Acquire the Expression of T-Bet and IFN-γto Destroy Tumor Cells In Vivo.

Programming tumor-reactive effector memory CD8 + T cells in vitro obviates the requirement for in vivo vaccination

Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers

Treatment of Large Established Murine Melanoma with Th17 Polarized CD4+ T Helper Cells Genetically Engineered to Express MHC Class IIRestricted T Cell Receptor

Tumor-specific Th17-polarized cells eradicate large established melanoma

IL-2 and IL-21 confer opposing differentiation programs to CD8 + T cells for adoptive immunotherapy

CTLA-4 dysregulation of self/tumor-reactive CD8 + T-cell function is CD4 + T-cell dependent

Partly MHC Matched Allogeneic Tumor Specific T Cells Mediate Tumor Regression without Inducing GVHD in Immunosuppressed Host.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only